First, the inhibitory effects of JapA on the expression of NFAT1 and its target genes, MDM2, c-Myc and COX-2, were shown in human breast cancer cells in vitro and breast xenograft tumors in vivo. The gene discussed is MYC; the disease is breast carcinoma.